Assignee
ELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD
CN·7 granted patents·3 pending applications·7 citations·filing 2018–2023
Top patents by PatentIndex Score
10 records- 0187US10813974B2Methods for treatment of HBV infectionELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2020·Granted Oct 27, 2020·3 cites·28 claims
- 0280US10968274B2Anti-interferon gamma antibodies and uses thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2018·Granted Apr 6, 2021·4 cites·9 claims
- 0368US2024182578A1Anti-pd-l1 antibodies and anti-pd-l1/il10 fusion proteinsELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2023·Application pending·0 cites
- 0465US12398205B2Anti-interferon gamma antibodies and uses thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2021·Granted Aug 26, 2025·0 cites·14 claims
- 0564US11773167B2Anti-PD-L1 antibodies and anti-PD-L1/IL10 fusion proteinsELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2022·Granted Oct 3, 2023·0 cites·4 claims
- 0664US2024190934A1Engineered interleukin-10 and fusion proteins thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2023·Application pending·0 cites
- 0763US12528862B2Anti-interferon gamma antibodies and uses thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2021·Granted Jan 20, 2026·0 cites·4 claims
- 0854US2024336667A1Method of treating diseases with anti-pd-l1/il-10 fusion proteinsELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2022·Application pending·0 cites
- 0953US12291567B2Antibodies to granulocyte-macrophage colony stimulating factor and uses thereofELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2021·Granted May 6, 2025·0 cites·18 claims
- 1050US11396549B2Anti-colony stimulating factor 1 receptor (CSF1R) antibodies and methods of use thereof for treating cancerELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD·Filed 2021·Granted Jul 26, 2022·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when ELIXIRON IMMUNOTHERAPEUTICS HONG KONG LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →